Mostrar el registro sencillo

dc.contributor.authorThong, Phan Quoc
dc.contributor.authorThu Huong, Le Thi
dc.contributor.authorTu, Nguyen Dac
dc.contributor.authorMy Nhung, Hoang Thi
dc.contributor.authorKhanh, Lam
dc.contributor.authorManh, Do Hung
dc.contributor.authorNam, Pham Hong
dc.contributor.authorPhuc, Nguyen Xuan
dc.contributor.authorAlonso Masa, Javier 
dc.contributor.authorQiao, Ju
dc.contributor.authorSridhar, Srinivas
dc.contributor.authorThu, Ha Phuong
dc.contributor.authorPhan, Manh Huong
dc.contributor.authorKim Thanh, Nguyen Thi
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-02-28T14:40:15Z
dc.date.available2023-02-28T14:40:15Z
dc.date.issued2022
dc.identifier.issn1743-5889
dc.identifier.issn1748-6963
dc.identifier.otherRED2018102626-Tes_ES
dc.identifier.otherMAT2017-83631-C3es_ES
dc.identifier.urihttps://hdl.handle.net/10902/27928
dc.description.abstractBackground: Despite medicinal advances, cancer is still a big problem requiring better diagnostic and treatment tools. Magnetic nanoparticle (MNP)-based nanosystems for multiple-purpose applications were developed for these unmet needs. Methods: This study fabricated novel trifunctional MNPs of Fe3O4@PLA-PEG for drug release, MRI and magnetic fluid hyperthermia. Result: The MNPs provided a significant loading of curcumin (∼11%) with controllable release ability, a high specific absorption rate of 82.2 W/g and significantly increased transverse relaxivity (r2 = 364.75 mM-1 s-1). The in vivo study confirmed that the MNPs enhanced MRI contrast in tumor observation and low-field magnetic fluid hyperthermia could effectively reduce the tumor size in mice bearing sarcoma 180. Conclusion: The nanocarrier has potential for drug release, cancer treatment monitoring and therapy.es_ES
dc.description.sponsorshipThe authors are grateful for the financial support by AOARD under award FA2386-17-1-4042. The Spanish government is acknowledged for the “Nanotechnology in translational hyperthermia (HIPERNANO)” research network (RED2018102626-T) and for funding under the project number MAT2017-83631-C3. NTK Thanh thanks EPSRC (EP/M015157/1). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.es_ES
dc.format.extent17 p.es_ES
dc.language.isoenges_ES
dc.publisherFuture Medicine Ltd.es_ES
dc.rights© 2023 The Authorses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceNanomedicine, 2022, 17(22), 1677-1693es_ES
dc.subject.otherCurcumines_ES
dc.subject.otherDrug deliveryes_ES
dc.subject.otherFe3O4 nanoparticleses_ES
dc.subject.otherhyperthermiaes_ES
dc.subject.otherMRIes_ES
dc.titleMultifunctional nanocarriers of Fe3O4@PLA-PEG/curcumin for MRI, magnetic hyperthermia and drug deliveryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.2217/nnm-2022-0070es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.2217/nnm-2022-0070
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2023 The AuthorsExcepto si se señala otra cosa, la licencia del ítem se describe como © 2023 The Authors